Mirae Asset Global ETFs Holdings
PBYI icon

Mirae Asset Global ETFs Holdings’s Puma Biotechnology PBYI Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165K Sell
20,383
-252
-1% -$1.84K ﹤0.01% 2582
2026
Q1 		$132K Buy
20,635
+476
+2% +$3.07K ﹤0.01% 2551
2025
Q4 		$120K Sell
20,159
-64
-0.3% -$340 ﹤0.01% 2585
2025
Q3 		$107K Sell
20,223
-3,542
-15% -$15K ﹤0.01% 2627
2025
Q2 		$81.5K Sell
23,765
-1,092
-4% -$3.49K ﹤0.01% 2710
2025
Q1 		$73.6K Buy
24,857
+1,092
+5% +$3.42K ﹤0.01% 2749
2024
Q4 		$72.5K Buy
23,765
+1,055
+5% +$3.07K ﹤0.01% 2820
2024
Q3 		$57.9K Buy
+22,710
New +$68.7K ﹤0.01% 2893

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PBYI Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Puma Biotechnology (PBYI) stake by 1.2% in Q2 2026, selling an estimated $1.84K and leaving 20,383 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #2582.

Mirae Asset Global ETFs Holdings first reported a position in PBYI in Q3 2024 and has held it in 8 quarters since. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 20,383 shares of Puma Biotechnology worth $165K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 252 Puma Biotechnology shares in Q2 2026, an estimated $1.84K.
  • Puma Biotechnology made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2582 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Puma Biotechnology in Q3 2024 and has held it in 8 quarters since.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.